Patient-Identified Most Bothersome Symptom in Patients With Chronic Migraine: An Analysis of PROMISE-2

被引：0

作者：

Lipton, R. B. ^{[1
]}

Dodick, D. W. ^{[2
]}

Ailani, J. ^{[3
]}

Winner, P. K. ^{[4
,5
,6
,7
]}

Hindiyeh, N. A. ^{[8
]}

Hirman, J. ^{[9
]}

Snapinn, S. ^{[10
]}

Mehta, L. ^{[10
]}

Cady, R. ^{[10
]}

机构：

[1] Albert Einstein Coll Med, Bronx, NY 10467 USA

[2] Mayo Clin, Scottsdale, AZ USA

[3] Georgetown Univ Hosp, Dept Neurol, Washington, DC 20007 USA

[4] Nova Southeastern Univ, Palm Beach Headache Ctr, W Palm Beach, FL USA

[5] Nova Southeastern Univ, Neurol Res Inst Palm Beach, W Palm Beach, FL USA

[6] Nova Southeastern Univ, Premiere Res Inst, W Palm Beach, FL USA

[7] Nova Southeastern Univ, Palm Beach Neurol, W Palm Beach, FL USA

[8] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[9] Pacific Northwest Stat Consulting Inc, Woodinville, WA USA

[10] Lundbeck Seattle BioPharmaceut Inc, Bothell, WA USA

来源：

HEADACHE | 2020年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：117 / 118

页数：2

共 50 条

[1] Patient-Identified Most Bothersome Symptom in Patients with Chronic Migraine: An Analysis of PROMISE-2
Lipton, Richard B.
Dodick, David W.
Ailani, Jessica
Winner, Paul
Hindiyeh, Nada A.
Hirman, Joe
Snapinn, Steven
Mehta, Lahar
Cady, Roger
[J]. NEUROLOGY, 2020, 94 (15)
[2] Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine prevention
Lipton, Richard B.
Goadsby, Peter J.
Dodick, David W.
McGinley, James S.
Houts, Carrie R.
Wirth, R. J.
Kymes, Steve
Ettrup, Anders
Osterberg, Ole
Cady, Roger
Ashina, Messoud
Buse, Dawn C.
[J]. HEADACHE, 2022, 62 (06): : 690 - 699
[3] Correlation Analysis of the Change in SF-36 with Change in Patient-Identified Most Bothersome Symptom and Monthly Migraine Days (MMDs) in Patients with Chronic Migraine (CM): Results of the PROMISE-2 Study
Young, William B.
Ailani, Jessica
Buse, Dawn C.
Horblyuk, Ruslan
Hirman, Joe
Cady, Roger
[J]. NEUROLOGY, 2020, 94 (15)
[4] CORRELATION ANALYSIS OF THE CHANGE IN THREE SF-36 DOMAINS WITH CHANGE IN PATIENT-IDENTIFIED MOST BOTHERSOME SYMPTOM AND MONTHLY MIGRAINE DAYS IN PATIENTS WITH CHRONIC MIGRAINE: RESULTS OF THE PROMISE-2 STUDY
Young, W. B.
Ailani, J.
Buse, D. C.
Horblyuk, R.
Hirman, J.
Cady, R.
[J]. VALUE IN HEALTH, 2020, 23 : S279 - S279
[5] Evaluating the Utility of Patient-Identified Most Bothersome Symptom for Migraine Research
Lipton, R. B.
Goadsby, P. J.
Dodick, D. W.
McGinley, J. S.
Houts, C. R.
Wirth, R. J.
Kymes, S.
Ettrup, A.
Osterberg, O.
Cady, R.
Ashina, M.
Buse, C.
[J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 46 - 46
[6] Evaluating the utility of patient-identified most bothersome symptom for migraine research
Lipton, R. B.
Goadsby, P. J.
Dodick, D. W.
McGinley, J. S.
Houts, C.
Wirth, R.
Kymes, S.
Ettrup, A.
Osterberg, O.
Cady, R.
Ashina, M.
Buse, D. C.
[J]. HEADACHE, 2021, 61 : 126 - 127
[7] Evaluating the Utility of Patient-Identified Most Bothersome Symptom for Migraine Research
Lipton, R. B.
Goadsby, P. J.
Dodick, D. W.
McGinley, J. S.
Houts, C. R.
Wirth, R. J.
Kymes, S.
Ettrup, A.
Osterberg, O.
Cady, R.
Ashina, M.
Buse, D. C.
[J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 69 - 69
[8] Patient-identified most bothersome symptom as a driver of health-related quality of life experienced by patients with migraine
Jonsson, Linus
Awad, Susanne F.
Regnier, Stephane A.
Talon, Brian
Kymes, Steven
Lee, Xin Ying
Goadsby, Peter J.
[J]. NEUROLOGY, 2023, 100 (17)
[9] Patient-identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient-centered outcome
Lipton, Richard B.
Dodick, David W.
Ailani, Jessica
McGill, Lora
Hirman, Joe
Cady, Roger
[J]. HEADACHE, 2021, 61 (05): : 766 - 776
[10] Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
Lipton, Richard B.
Goadsby, Peter J.
Smith, Jeff
Schaeffler, Barbara A.
Biondi, David M.
Hirman, Joe
Pederson, Susan
Allan, Brent
Cady, Roger
[J]. NEUROLOGY, 2020, 94 (13) : E1365 - E1377

← 1 2 3 4 5 →